Published in Arch Neurol on April 01, 1991
Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training. Parkinsonism Relat Disord (2008) 1.05
Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders. Pharmacol Ther (2014) 0.94
Advances in non-dopaminergic treatments for Parkinson's disease. Front Neurosci (2014) 0.93
Assessing the role of dopamine in limb and cranial-oromotor control in a rat model of Parkinson's disease. J Commun Disord (2011) 0.90
Targeted exercise therapy for voice and swallow in persons with Parkinson's disease. Brain Res (2010) 0.88
Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems. Compr Physiol (2013) 0.88
Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease. Hum Brain Mapp (2012) 0.84
Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole. J Neural Transm (Vienna) (1997) 0.77
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999) 32.32
Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem (1989) 2.75
Promoting responsible conduct in research through "survival skills" workshops: some mentoring is best done in a crowd. Sci Eng Ethics (2001) 2.01
Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci U S A (1996) 1.75
Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci (2001) 1.66
Treatment of Parkinson's disease. N Engl J Med (1993) 1.58
Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience (1988) 1.54
Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience (1995) 1.37
Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res (1990) 1.20
Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats. J Pharmacol Exp Ther (1977) 1.15
The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochem Res (1997) 1.09
Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J Neurochem (1995) 1.09
Amphetamine and operant behavior in rats: relationship between drug effect and control response rate. J Comp Physiol Psychol (1974) 1.08
Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience (2001) 1.07
Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat. J Neurochem (1994) 1.07
The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart. Br J Pharmacol (1983) 1.06
Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch Neurol (1984) 1.06
Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione. J Neurochem (1994) 1.05
Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J Neurochem (1996) 1.04
Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem (1995) 1.02
Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease. Adv Exp Med Biol (1996) 1.02
Maternal separation alters nerve growth factor and corticosterone levels but not the DNA methylation status of the exon 1(7) glucocorticoid receptor promoter region. Metab Brain Dis (2009) 0.99
Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience (1997) 0.98
Increased transcription of the tyrosine hydroxylase gene in individual locus coeruleus neurons following footshock stress. Neuroscience (2000) 0.97
Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res (1984) 0.94
Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences. Neuroscience (1997) 0.94
In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids. J Neural Transm Gen Sect (1993) 0.92
Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions. Neuroscience (1990) 0.92
Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor. J Neurosci (1991) 0.92
Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats. Science (1972) 0.92
Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis. J Neurosci (1989) 0.89
Paradoxical kinesia in parkinsonism is not caused by dopamine release. Studies in an animal model. Arch Neurol (1989) 0.89
Parkinson's disease: studies with an animal model. Life Sci (1984) 0.89
Stress-induced neurological impairments in an animal model of parkinsonism. Ann Neurol (1985) 0.89
Impact of corticotropin-releasing hormone on extracellular norepinephrine in prefrontal cortex after chronic cold stress. J Neurochem (1997) 0.89
Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science (1973) 0.88
Effects of cold exposure on rat adrenal tyrosine hydroxylase: an analysis of RNA, protein, enzyme activity, and cofactor levels. J Neurochem (1990) 0.87
Effect of chronic cold exposure on tyrosine hydroxylase mRNA in rat adrenal gland. Brain Res (1985) 0.87
Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage. J Neurosci (1987) 0.87
Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time. Neuropsychopharmacology (2002) 0.87
Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids. J Neurochem (1993) 0.87
Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites. J Neural Transm Suppl (1997) 0.86
Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. J Pharmacol Exp Ther (1990) 0.86
Inhibitory glutamatergic regulation of evoked dopamine release in striatum. Neuroscience (2000) 0.86
Recovery of hippocampal dentate granule cell responsiveness to entorhinal cortical input following norepinephrine depletion. Brain Res (1993) 0.85
Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion. Brain Res (1989) 0.85
Intrahypothalamic injections of kainic acid produce feeding and drinking deficits in rats. Brain Res (1978) 0.85
Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats. Exp Neurol (2005) 0.85
Tyrosine hydroxylase activity and catecholamine biosynthesis in the adrenal medulla of rats during stress. J Pharmacol Exp Ther (1985) 0.85
High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment. J Neurochem (1984) 0.84
High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. J Pharmacol Exp Ther (1991) 0.84
Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis. Brain Res (1986) 0.84
The effect of altered dopaminergic activity on food intake in the rat: evidence for an optimal level of dopaminergic activity for behavior. Prog Neuropsychopharmacol (1980) 0.84
Environmental stress increases extracellular dopamine in striatum of 6-hydroxydopamine-treated rats: in vivo microdialysis studies. Brain Res (1990) 0.84
Characterization of [3H]GABA release from striatal slices: evidence for a calcium-independent process via the GABA uptake system. Neuroscience (1988) 0.84
Hepatic tyrosine transaminase rhythm: interaction of environmental lighting, food consumption and dietary protein content. J Nutr (1969) 0.83
Maternal separation exaggerates the toxic effects of 6-hydroxydopamine in rats: implications for neurodegenerative disorders. Stress (2008) 0.83
Incubation of tissue slices in the absence of Ca2+ and Mg2+ can cause nonspecific damage. J Neurochem (1991) 0.83
Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm. Psychopharmacology (Berl) (2000) 0.83
Sensitization of norepinephrine release in medial prefrontal cortex: effect of different chronic stress protocols. Brain Res (1999) 0.82
Brain catecholamines and the central control of food intake. Int J Obes (1984) 0.82
Analysis of tyrosine hydroxylase gene transcription using an intron specific probe. J Neurosci Methods (2000) 0.82
Muscarinic receptor subclasses: evidence from binding studies. Adv Biochem Psychopharmacol (1983) 0.82
The effects of L-dopa on in vitro dopamine release from striatum. Brain Res (1990) 0.82
Short- and long-term changes in adrenal tyrosine hydroxylase activity during insulin-induced hypoglycemia and cold stress. Brain Res (1983) 0.81
The effect of L-dopa on in vivo dopamine release from nigrostriatal bundle neurons. Brain Res (1988) 0.81
Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine. Eur J Pharmacol (1989) 0.81
Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine. Biochem Pharmacol (1986) 0.81
Daily rhythm in the accumulation of brain catechol-amines synthesized fom circulating H3-tyrosine. J Pharmacol Exp Ther (1970) 0.81
Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum. Brain Res Bull (1998) 0.81
Compensatory increase in tyrosine hydroxylase activity in rat brain after intraventricular injections of 6-hydroxydopamine. Science (1980) 0.80
Subtotal destruction of central noradrenergic projections increases the firing rate of locus coeruleus cells. Brain Res (1983) 0.80
Do the right thing. Curr Biol (1999) 0.80
Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine. J Pharmacol Exp Ther (1993) 0.80
A radioenzymatic assay for catecholamines and dihydroxyphenylacetic acid. Life Sci (1978) 0.80
Effect of haloperidol on dopamine synthesis and tyrosine hydroxylase in striatal synaptosomes. J Pharmacol Exp Ther (1979) 0.80
High affinity choline uptake in striatum and hippocampus: differential effects of treatments which release acetylcholine. Life Sci (1978) 0.80
Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion. Experientia (1980) 0.80
Molecular adaptations in catecholamine biosynthesis induced by cold stress and sympathectomy. J Neurosci Res (1986) 0.80
Olfactory bulb removal: effects on brain norepinephrine. Proc Natl Acad Sci U S A (1969) 0.79
Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience (1992) 0.79
Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats. J Comp Physiol Psychol (1974) 0.79
Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study. J Comp Neurol (1986) 0.79
Short and long term changes in tyrosine hydroxylase activity in rat brain after subtotal destruction of central noradrenergic neurons. J Neurosci (1981) 0.79
Effects of NADH on dopamine release in rat striatum. Synapse (2000) 0.79
Caffeine restores feeding response to 2-deoxy-D-glucose in 6-hydroxydopamine-treated rats. Nature (1977) 0.79
Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum. Eur J Pharmacol (1985) 0.79
Effect of dopamine-depleting brain lesions in rat pups: role of striatal serotonergic neurons in behavior. Behav Neurosci (1987) 0.78
Tyrosine hydroxylase content of residual striatal dopamine nerve terminals following 6-hydroxydopamine administration: a flow cytometric study. J Neurochem (1989) 0.78
Ingestive behavior following damage to central dopamine neurons: implications for homeostasis and recovery of function. Adv Biochem Psychopharmacol (1974) 0.78
Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: relation to behavioral recovery. Brain Res (1986) 0.77
Dopamine may influence striatal GABA release via three separate mechanisms. Brain Res (1989) 0.77
Neural control of adenylate cyclase responsiveness in brown adipose tissue. J Pharmacol Exp Ther (1985) 0.77
Rats given dopamine-depleting brain lesions as neonates do not respond to acute homeostatic imbalances as adults. Behav Neurosci (1986) 0.77
Acute homeostatic imbalances reinstate sensorimotor dysfunctions in rats with lateral hypothalamic lesions. J Comp Physiol Psychol (1979) 0.77
Glucoregulatory feeding by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science (1975) 0.77
Studies on the interaction between catecholamines and tyrosine aminotransferase in brain. Biochem Pharmacol (1973) 0.77
Environmental stimuli but not homeostatic challenges produce apparent increases in dopaminergic activity in the striatum: an analysis by in vivo voltammetry. Brain Res (1983) 0.77
Selective presynaptic cholinergic neurotoxicity following intrahippocampal AF64A injection in rats. J Neurochem (1983) 0.77
A cholinergic antagonist blocks cold stress-induced alterations in rat adrenal tyrosine hydroxylase mRNA. Brain Res (1988) 0.76